A key finding in the report was that several multinational firms had launched drugs without conducting mandatory clinical trials or seeking expert medical opinion The health ministry has denied the presence of any systemic rot in the drug approval process and pharmaceutical firms have refuted charges of collusion after a report by a parliamentary panel pointed to regulatory lapses in clinical trials. The panel, which looked into the functioning of Central Drugs...
More »SEARCH RESULT
Panel exposes flaws in India’s drug approval procedure-Vidya Krishnan
A report by a parliamentary committee has shown that the drug industry regulator, the Drug Controller General of India (DCGI), has been approving, on average, one new drug a month without conducting mandatory clinical trials or seeking expert medical opinion—findings that expose the deep flaws prevalent in India’s drug approval process. The committee has asked the health ministry to withdraw the discretionary powers given to the Central Drugs Standard Control Organization...
More »Unique identity crisis-Latha Jishnu, Jyotika Sood
-Down to Earth Biometric-based unique identity or Aadhaar is leading to huge problems for people working for the rural employment guarantee scheme and for others receiving welfare benefits. Not only have enrolments been done shoddily but the experience of the pilot projects shows that it is almost impossible to authenticate the work-hardened fingerprints of the poor, find Latha Jishnu and Jyotika Sood. Besides, there is the overwhelming issue of deficient online...
More »Media Follies and Supreme Infallibility by Sukumar Muralidharan
The Supreme Court has taken steps to lay down a code for media reporting. This attempt at prior restraint on the media is a dangerous move with precedent from authoritarian polities. In a context where the judiciary has been lax in defending the media from attacks which seek to curb its freedom, such unilateral moves will not remedy bad reporting but rather make conditions worse for the media to play...
More »India Serves Up Costly Cocktail of Vaccines by Ranjit Devraj
Ignoring widespread concern over the safety, Efficacy and cost of pentavalent vaccines, India’s central health ministry has, this month, approved inclusion of the prophylactic cocktail in the universal immunisation programme in seven of its provinces. Pentavalent vaccine doses, a cocktail of five antigens in a single shot, confers immunity against five paediatric diseases - diphtheria, pertussis, tetanus, hepatitis B and haemophilus influenza type b (Hib), with the last one considered particularly...
More »